Nuclear remodeling of telomeres in chronic myeloid leukemia

Genes Chromosomes and Cancer

Volumn 52, Issue 5, 2013, Pages 495-502

  Samassekou, Oumar ^a,b   Hébert, Josée ^c   Mai, Sabine ^b   Yan, Ju ^a  

^a UNIVERSITY OF SHERBROOKE   (Canada)

^b UNIVERSITY OF MANITOBA   (Canada)

^c MAISONNEUVE ROSEMONT HOSPITAL   (Canada)

Author keywords

[No Author keywords available]

Indexed keywords

ARTICLE; CANCER CELL; CANCER STAGING; CELL AGGREGATION; CELL NUCLEUS; CELLULAR DISTRIBUTION; CHROMATIN ASSEMBLY AND DISASSEMBLY; CHROMOSOME NUMBER; CHRONIC MYELOID LEUKEMIA; CLINICAL ARTICLE; CONTROLLED STUDY; CYTOARCHITECTURE; FLUORESCENCE IN SITU HYBRIDIZATION; GENOMIC INSTABILITY; HUMAN; HUMAN CELL; HUMAN TISSUE; PRIORITY JOURNAL; QUANTITATIVE ANALYSIS; TELOMERE;

CASE-CONTROL STUDIES; CELL NUCLEUS; CELL NUCLEUS SIZE; GENOMIC INSTABILITY; HUMANS; IN SITU HYBRIDIZATION, FLUORESCENCE; INTERPHASE; LEUKEMIA, MYELOGENOUS, CHRONIC, BCR-ABL POSITIVE; MICROSCOPY, FLUORESCENCE; TELOMERE; TUMOR CELLS, CULTURED;

EID: 84875064962     PISSN: 10452257     EISSN: 10982264     Source Type: Journal    
DOI: 10.1002/gcc.22046     Document Type: Article

References (23)

1. Artandi SE, DePinho RA. 2010. Telomeres and telomerase in cancer. Carcinogenesis 31: 9-18.
2. Boultwood J, Fidler C, Shepherd P, Watkins F, Snowball J, Haynes S, Kusec R, Gaiger A, Littlewood TJ, Peniket AJ, Wainscoat JS. 1999. Telomere length shortening is associated with disease evolution in chronic myelogenous leukemia. Am J Hematol 61: 5-9.
3. Campbell LJ, Fidler C, Eagleton H, Peniket A, Kusec R, Gal S, Littlewood TJ, Wainscoat JS, Boultwood J. 2006. hTERT, the catalytic component of telomerase, is downregulated in the haematopoietic stem cells of patients with chronic myeloid leukaemia. Leukemia 20: 671-679.
4. Chuang TC, Moshir S, Garini Y, Chuang AY, Young IT, Vermolen B, van den Doel R, Mougey V, Perrin M, Braun M, Kerr PD, Fest T, Boukamp P, Mai S. 2004. The three-dimensional organization of telomeres in the nucleus of mammalian cells. BMC Biol 2: 12.
5. Gadji M, Fortin D, Tsanaclis AM, Garini Y, Katzir N, Wienburg Y, Yan J, Klewes L, Klonisch T, Drouin R, Mai S. 2010. Three-dimensional nuclear telomere architecture is associated with differential time to progression and overall survival in glioblastoma patients. Neoplasia 12: 183-191.
6. Gadji M, Adebayo Awe J, Rodrigues P, Kumar R, Houston DS, Klewes L, Dièye TN, Rego EM, Passetto RF, de Oliveira FM, Mai S. 2012. Profiling three-dimensional nuclear telomeric architecture of myelodysplastic syndromes and acute myeloid leukemia defines patient subgroups. Clin Cancer Res 18: 3293-3304.
7. Greider CW, Blackburn EH. 1985. Identification of a specific telomere terminal transferase activity in Tetrahymena extracts. Cell 43: 405-413.
8. Guffei A, Lichtensztejn Z, Goncalves Dos Santos Silva A, Louis SF, Caporali A, Mai S. 2007. c-Myc-dependent formation of Robertsonian translocation chromosomes in mouse cells. Neoplasia 9: 578-588.
9. Knecht H, Sawan B, Lichtensztejn D, Lemieux B, Wellinger RJ, Mai S. 2009. The 3D nuclear organization of telomeres marks the transition from Hodgkin to Reed-Sternberg cells. Leukemia 23: 565-573.
10. Knecht H, Kongruttanachok N, Sawan B, Brossard J, Prévost S, Turcotte E, Lichtensztejn Z, Lichtensztejn D, Mai S. 2012. Three-dimensional telomere signatures of Hodgkin- and Reed-Sternberg cells at diagnosis identify patients with poor response to conventional chemotherapy. Transl Oncol 5: 269-277.
11. Lingner J, Cooper JP, Cech TR. 1995. Telomerase and DNA end replication: No longer a lagging strand problem? Science 269: 1533-1534.
12. Louis SF, Vermolen BJ, Garini Y, Young IT, Guffei A, Lichtensztejn Z, Kuttler F, Chuang TC, Moshir S, Mougey V, Chuang AY, Kerr PD, Fest T, Boukamp P, Mai S. 2005. c-Myc induces chromosomal rearrangements through telomere and chromosome remodeling in the interphase nucleus. Proc Natl Acad Sci USA 102: 9613-9618.
13. Mai S. 2010. Initiation of telomere-mediated chromosomal rearrangements in cancer. J Cell Biochem 109: 1095-1102.
14. Mai S, Garini Y. 2006. The significance of telomeric aggregates in the interphase nuclei of tumor cells. J Cell Biochem 97: 904-915.
15. Mitelman F. 1993. The cytogenetic scenario of chronic myeloid leukemia. Leuk Lymphoma 1: 11-15.
16. Quintas-Cardama A, Cortes J. 2009. Molecular biology of bcr-abl1-positive chronic myeloid leukemia. Blood 113: 1619-1630.
17. Rowley JD. 1973. A new consistent chromosomal abnormality in chronic myelogenous leukaemia identified by quinacrine fluorescence and Giemsa staining. Nature 243: 290-293.
18. Samassekou O, Ntwari A, Hebert J, Yan J. 2009. Individual telomere lengths in chronic myeloid leukemia. Neoplasia 11: 1146-1154.
19. Samassekou O, Li H, Hébert J, Ntwari A, Wang H, Cliche CG, Bouchard E, Huang S, Yan J. 2011. Chromosome-arm-specific long telomeres: A new clonal event in primary chronic myelogenous leukemia cells. Neoplasia 13: 550-560.
20. Schaefer LH, Schuster D, Herz H. 2001. Generalized approach for accelerated maximum likelihood based image restoration applied to three-dimensional fluorescence microscopy. J Microsc 204: 99-107.
21. Sfeir AJ, Chai W, Shay JW, Wright WE. 2005. Telomere-end processing the terminal nucleotides of human chromosomes. Mol Cell 18: 131-138.
22. Solovei I, Cavallo A, Schermelleh L, Jaunin F, Scasselati C, Cmarko D, Cremer C, Fakan S, Cremer T. 2002. Spatial preservation of nuclear chromatin architecture during three-dimensional fluorescence in situ hybridization (3D-FISH). Exp Cell Res 276: 10-23.
23. Vermolen BJ, Garini Y, Mai S, Mougey V, Fest T, Chuang TC, Chuang AY, Wark L, Young IT. 2005. Characterizing the three-dimensional organization of telomeres. Cytometry A 67: 144-150.